APEX BIOTECHNOLOGY CORP. Apex Biotechnology Corp. Stock
Equities
1733
TW0001733004
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.4 TWD | -0.15% |
|
-1.04% | -17.12% |
| Sales 2022 | 2.24B 68.93M | Sales 2023 | 1.68B 51.49M | Capitalization | 4.03B 124M |
|---|---|---|---|---|---|
| Net income 2022 | 182M 5.59M | Net income 2023 | 116M 3.56M | EV / Sales 2022 | 1.04 x |
| Net cash position 2022 | 217M 6.66M | Net cash position 2023 | 291M 8.92M | EV / Sales 2023 | 2.23 x |
| P/E ratio 2022 |
14.1
x | P/E ratio 2023 |
35
x | Employees | - |
| Yield 2022 |
5.48% | Yield 2023 |
2.73% | Free-Float | 83.95% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.15% | ||
| 1 week | -1.04% | ||
| Current month | -1.04% | ||
| 1 month | -1.76% | ||
| 3 months | -0.60% | ||
| 6 months | +27.48% | ||
| Current year | -17.12% |
1 week
33.00
34.25
1 month
33.0037.80
Current year
30.8043.80
1 year
25.6044.45
3 years
22.4544.45
5 years
17.3044.45
10 years
17.3067.50
| Managers | Title | Age | Since |
|---|---|---|---|
Yan Shih Shen
CEO | Chief Executive Officer | - | - |
Ying Hsiang Chu
DFI | Director of Finance/CFO | - | - |
Tammy Wu
ADM | Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Meng Wen Yang
BRD | Director/Board Member | - | - |
Yan Shih Shen
CEO | Chief Executive Officer | - | - |
Chin Chang Pao
BRD | Director/Board Member | - | 18-05-24 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 33.4 | -0.15% | 222,703 |
| 24-04-22 | 33.45 | -0.15% | 423,591 |
| 24-04-19 | 33.5 | -1.03% | 901,807 |
| 24-04-18 | 33.85 | -0.44% | 269,984 |
| 24-04-17 | 34 | +0.74% | 458,670 |
End-of-day quote Taiwan S.E., April 22, 2024
More quotes
APEX BIOTECHNOLOGY CORP is a Taiwan-based company principally engaged in the research, development, manufacture and distribution of testing strips, electrode testing strips and tester suites. The Company primarily provides testing strips and monitoring systems, including blood glucose monitoring systems, uric acid monitoring systems, pesticide residue detection systems, lactate monitoring systems and hemachrome testing systems, among others. Its blood glucose monitoring systems and uric acid monitoring systems are mainly used by patients, doctors and nurses in hospitals and clinics. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and the rest of Asia.
Calendar
2024-04-29
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -17.12% | 102M | |
| +72.39% | 12.32B | |
| -18.22% | 7.96B | |
| +16.84% | 7.25B | |
| +3.25% | 5.84B | |
| +8.16% | 5.11B | |
| +19.97% | 4.28B | |
| -19.84% | 4B | |
| -42.79% | 2.15B | |
| +1.36% | 2.01B |
- Stock Market
- Equities
- 1733 Stock
